Alere iCup DX Pro2 - immunochromatography (competitive)
Performed at authorized locations by point of care operators. Includes: Amphetamines, Barbiturates, Benzodiazepines, Buprenorphine, Cocaine, Methamphetamine, Opiates, Oxycodone, Methadone, and THC. Three tests that can assist in the detection of adulteration of the specimen are also included: creatinine, specific gravity, and oxidizing agent detection. The Alere ICup DX Pro2 is a qualitative urine drug screen and is for medical purposes only. It is not for pre-employment or legal testing purposes.
Reference ranges are available in the Urine Drug Screen Alere iCup DX Pro 2 procedure located on the POC website: https://www.pathology.med.umich.edu/point-of-care
• Please see the Urine Drug Screen Alere iCup DX Pro 2 procedure located on the POC website: https://www.pathology.med.umich.edu/point-of-care for drug specific detection levels and interferences.
•This test has been developed for testing urine samples only. No other fluids have been evaluated.
•Adulterated urine samples may produce erroneous results. Strong oxidizing agents such as bleach (hypochlorite) can oxidize drug analytes. If a sample is suspected of being adulterated, obtain a new sample in a different, unused cup.
• This test is a qualitative screening assay. It is not designed to determine the quantitative concentration of drugs or the level of intoxication.
• This assay provides only preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography- mass spectrometry (LC-MS/MS) are the preferred confirmatory methods. Clinical consideration and professional judgement should be applied to any drug test result, particularly when preliminary positive results are indicated.
Collect freshly voided, untreated urine into a plastic urine cup.
For more test specific information, please refer to the test procedure found on the Michigan Medicine POC website: https://www.pathology.med.umich.edu/point-of-care